platoseed
Unleashing the potential of DNA and RNA based therapies using AI
We have developed an AI platform enabling to accelerate the discovery and the design of genomic therapies such as Cell Therapies, RNA Therapies and DNA Therapies.
WhiteLab Genomics applies AI to biological data to accelerate and de-risk genomic medicine and drug design. They offer an AI-powered platform (ALFRED) that optimizes molecular constructs for safety and efficacy across gene therapy modalities and delivery systems.
ALFRED is described as an AI-led framework that combines advanced algorithms, curated databases, and computational biology to optimize therapeutic candidates for safety and efficacy across modalities such as AAV, lentivirus, and nanoparticles. The platform targets design tasks including RNA-based therapies, receptor identification, viral vector design, payload design, and vectors optimization, supported by in silico design and wet-lab validation workflows to accelerate R&D across CNS, ophthalmology, rare diseases, oncology, and neurology programs.
Who it’s for: Biotech/health companies and pharmaceutical developers engaged in genomic medicines, gene therapies, viral vectors, and RNA-based therapies seeking AI-assisted design and drug development acceleration.
Hiring/Careers section; partnerships and collaboration mentions; mentions of YC backing and industry collaborations
23 y of experience in healthcare innovation with multiple executive roles in Business Development, Marketing and Commercial Operations. Former GE Healthcare. MBA Chicago Booth, Biomedical Engineer MS University of Compiègne, France.
Senior application scientist at Genomic Vision, leading provider of genetic devices and platform Research fellow at Rockefeller Univ & Necker Hospital on human complex immune deficiencies in J-L Casanova’s lab PhD in genetics, molecular biology & immunology at Université Pierre & Marie CurieWith Honors

Using CRISPR to find treatments for cancer and inflammation

A platform to make artificial viruses as cancer therapeutics.